This inventor holds 1 USPTO granted patent and 3 published patent applications and 1 EPO patent. Top assignees: Algenics, L'institut Francais De Recherche Pour L'exploitation De La Mer (Ifremer), Université´de Rouen. Active years: 2017.
Company Filing History:
1 out of 1 
1 out of 1 
1 out of 33 
Years Active: 2017
Title: Rémy Michel: Innovator in Glycosylation Technology
Introduction
Rémy Michel is a notable inventor based in Nantes, France. He has made significant contributions to the field of biotechnology, particularly in the area of glycosylation. His work has implications for the production of glycosylated polypeptides, which are essential in various biopharmaceutical applications.
Latest Patents
Rémy Michel holds a patent that involves a transformed organism containing a nucleic acid sequence operatively linked to a promoter. This sequence encodes an N-acetylglucosaminyltransferase I and/or an α-Mannosidase II. Notably, at least one β-N-acetylglucosaminidase of the transformed organism has been inactivated. The method for producing a glycosylated polypeptide includes culturing this transformed organism and purifying the expressed and glycosylated polypeptide.
Career Highlights
Throughout his career, Rémy Michel has worked with prominent organizations such as Algenics and Université de Rouen. His experience in these institutions has allowed him to develop and refine his innovative approaches to biotechnology.
Collaborations
Rémy has collaborated with several professionals in his field, including Romain Louvet and Carole Burel. Their teamwork has contributed to advancements in the research and application of glycosylation technologies.
Conclusion
Rémy Michel's contributions to biotechnology, particularly in glycosylation, highlight his role as an influential inventor. His patent and collaborations reflect his commitment to advancing the field and improving biopharmaceutical production methods.